Dark

THTX
Theratechnologies Inc. Common
stock NASDAQ

Market Open

May 9, 2025 2:33:43 PM EDT

2.61USD-4.927%(-0.13)202,442

2.60Bid 2.61Ask 0.01Spread

Pre-market

May 8, 2025 9:27:30 AM EDT

2.71USD-1.095%(-0.03)0

After-hours

May 8, 2025 4:36:30 PM EDT

2.75USD+0.917%(+0.03)0

OverviewOptionsHistoricalExchangesShortsNews

Dec 6, 2021

11:53AM EST Theratechnologies Submits Supplemental Biologics License Application To FDA Advancing Development Of IV Push Trogarzo For Patients Living With HIV Benzinga

11:52AM EST Theratechnologies Submits Supplemental Biologics License GlobeNewswire Inc

Nov 26, 2021

01:06PM EST Theratechnologies Inc. (Theratechnologies, or Company) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, is pleased to announce that it was awarded of the 2021 Innovation Award in the Life Sciences category at the 31st ADRIQ Innovation Awards Gala held on November 25, 2021. GlobeNewswire Inc

Nov 23, 2021

10:00AM EST Theratechnologies Announces Renewal Of Shelf Prospectus And Registration Statement; At-The-Market Facility To Be Extended Benzinga

09:47AM EST Theratechnologies Announces Renewal of Shelf Prospectus and Registration PR Newswire

Nov 3, 2021

07:30AM EDT Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced that Paul Levesque, President and Chief Executive Officer, will present at the Credit Suisse 30th Annual Healthcare Conference on November 11, 2021 at 9:40 a.m. ET. GlobeNewswire Inc

Oct 26, 2021

02:00AM EDT Theratechnologies Announces Reimbursement Agreement in Italy for GlobeNewswire Inc

Oct 22, 2021

09:16AM EDT Theratechnologies Highlights Publication In Frontiers In Oncology Journal Highlighting SORT1+ Technology For Targeting SORT1-Mediated Vasculogenic Mimicry Benzinga

09:15AM EDT Theratechnologies Announces Publication in Frontiers in Oncology GlobeNewswire Inc

Oct 13, 2021

01:38PM EDT Theratechnologies Q3 Earnings Lags Consensus As Trogarzo Sales Decline Benzinga

01:38PM EDT The Daily Biotech Pulse: FDA Nod For Lilly, Regulus Slumps On Study Discontinuation, ObSeva Strikes Linzagolix Commercialization Deal Benzinga

01:38PM EDT Theratechnologies Q3 EPS $(0.10) Misses $(0.07) Estimate Benzinga

07:00AM EDT Theratechnologies Reports Financial Resultsfor the GlobeNewswire Inc

03:36AM EDT Earnings Scheduled For October 13, 2021 Benzinga

Oct 10, 2021

11:59AM EDT The Week Ahead In Biotech (Oct. 10-16): Avadel FDA Decision, Conference Presentations and IPOs Take Center Stage Benzinga

Oct 6, 2021

08:30AM EDT Theratechnologies to Present at the H.C. Wainwright 5th Annual GlobeNewswire Inc

Oct 3, 2021

02:21PM EDT The Week Ahead In Biotech (Oct. 3-9): ChemoCentryx FDA Decision, Conference Presentations, IPOs and More Benzinga

Sep 29, 2021

08:30AM EDT Theratechnologies Inc. (TSX: TH) (NASDAQ: THTX) (Theratechnologies), a biopharmaceutical company focused on the development and commercialization of innovative therapies, announced today that it will report financial results for its third quarter of fiscal 2021 ended August 31, 2021 on Wednesday, October 13, 2021. GlobeNewswire Inc

Sep 22, 2021

08:12AM EDT Theratechnologies Announces Results For Trogarzo IV Push Administration; Says TMB-302 Study Results Demonstrate There Was No Difference In Pharmacokinetics Between IV Push And IV Infusion Benzinga

08:09AM EDT - TMB-302 study results demonstrate that there was no difference in pharmacokinetics between IV Push and IV Infusion - GlobeNewswire Inc

Sep 16, 2021

09:02AM EDT Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced that Paul Levesque, President and Chief Executive Officer, will participate in a fireside chat at the Cantor Fitzgerald Global Healthcare Conference on September 29, 2021 at 10:00 a.m. ET. GlobeNewswire Inc

Aug 13, 2021

09:18AM EDT Theratechnologies Highlights Publication Of TH1902 Preclinical Data In Peer-Reviewed Journal, Cancer Science Benzinga

09:09AM EDT Theratechnologies Announces Publication of TH1902 Preclinical Data GlobeNewswire Inc

Aug 4, 2021

08:00AM EDT Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced that Paul Levesque, President and Chief Executive Officer will participate in a fireside chat at the Canaccord Genuity 41st Annual Growth Conference on Wednesday, August 11, 2021 at 2:00 p.m. ET. GlobeNewswire Inc

Jul 29, 2021

10:39AM EDT Benzinga's Top Ratings Upgrades, Downgrades For July 29, 2021 Benzinga

09:12AM EDT 10 Biggest Price Target Changes For Thursday Benzinga

08:12AM EDT Canaccord Genuity Downgrades Theratechnologies to Hold, Lowers Price Target to $3 Benzinga

Jul 15, 2021

08:08AM EDT The Daily Biotech Pulse: Galapagos Sinks On Data, J&J Recalls Sunscreen Products, FibroGen Awaits AdCom Verdict, 3 IPOs Benzinga

07:56AM EDT Theratechnologies In Search Of Potential Partner For Late-Stage NASH Study Of Tesamorelin, Reports Q2 Earnings Benzinga

07:06AM EDT Theratechnologies Q2 EPS $(0.07) Up From $(0.08) YoY Benzinga

07:00AM EDT Theratechnologies Reports Financial Results for the Second Quarter GlobeNewswire Inc

04:26AM EDT Earnings Scheduled For July 15, 2021 Benzinga

Jun 30, 2021

11:28AM EDT In a release issued this morning, Wednesday, June 30, 2021, under the same headline, byTheratechnologies Inc. (TSX: TH) (NASDAQ: THTX), please note that in the last sentence of the first paragraph, the date should be Thursday, July 15, 2021, not Wednesday July 15, 2021. The corrected release follows: GlobeNewswire Inc

07:30AM EDT Theratechnologies Inc. (TSX: TH) (NASDAQ: THTX) (Theratechnologies), a biopharmaceutical company focused on the development and commercialization of innovative therapies announced today that it will report its financial results for the second quarter of fiscal 2021 ended May 31, 2021 on Wednesday, July 15, 2021. GlobeNewswire Inc

Jun 23, 2021

07:30AM EDT Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced the appointment of Mr. Frank Holler as a new independent member to its Board of Directors. GlobeNewswire Inc

Jun 21, 2021

11:38AM EDT Theratechnologies Peptide-Drug Conjugate Shows Better Anti-Metastatic Activity Compared With Docetaxel Alone Benzinga

09:05AM EDT Theratechnologies Announces New Preclinical Findings for Its Lead Investigational Peptide-Drug Conjugate TH1902 for the Potential Treatment of Metastatic Cancers Benzinga

09:00AM EDT Demonstrates better anti-metastatic activity compared with docetaxel alone GlobeNewswire Inc

Jun 10, 2021

04:01PM EDT Theratechnologies to Host Key Opinion Leader Event to Discuss its GlobeNewswire Inc

May 31, 2021

08:00AM EDT Theratechnologies Inc. (Theratechnologies, or the Company (TSX: TH) (NASDAQ: THTX)), a biopharmaceutical company focused on the development and commercialization of innovative therapies, is pleased to announce that Mr. Andr Dupras is joining the Company as Vice President, Human Resources. GlobeNewswire Inc

May 20, 2021

07:34AM EDT Theratechnologies Announces Results From Two Posters Presented at ACTHIV 2021 Annual Meeting Highlighting Positive Patient Experience With Trogarzo Benzinga

07:30AM EDT Theratechnologies Announces Results From Two Posters Presented at GlobeNewswire Inc

May 18, 2021

09:24AM EDT Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced that Paul Levesque, President and Chief Executive Officer will participate in a virtual fireside chat hosted by Edward Nash at Canaccord Genuity on Thursday, May 20, 2021 at 2:00 p.m. ET. GlobeNewswire Inc

May 13, 2021

11:16AM EDT Theratechnologies Inc. (Theratechnologies, or Company) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today held its annual meeting of shareholders. GlobeNewswire Inc

Apr 19, 2021

09:32AM EDT Canaccord Genuity Maintains Buy on Theratechnologies, Raises Price Target to $8 Benzinga

Apr 14, 2021

07:51AM EDT The Daily Biotech Pulse: Novavax CFO Departs, Zai Lab Inks Cancer Drug Collaboration, FDA Nod For Gilead Benzinga

07:30AM EDT Theratechnologies Inc. (Theratechnologies, or Company) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today reported business highlights and financial results for the first quarter ended February 28, 2021 (Q1 Fiscal 2021). GlobeNewswire Inc

Apr 12, 2021

04:30PM EDT Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced that Paul Levesque, President and Chief Executive Officer will present at the Bloom Burton & Co. Healthcare Investor Conference on Wednesday, April 21, 2021 at 10:30 a.m. ET. GlobeNewswire Inc

01:47PM EDT Theratechnologies Inc. (TSX: TH) (NASDAQ: THTX) (Theratechnologies), a biopharmaceutical company focused on the development and commercialization of innovative therapies announced today that it will report its financial results for the first quarter of fiscal 2021 ended February 28, 2021 on Wednesday, April 14, 2021. GlobeNewswire Inc

Apr 10, 2021

10:03AM EDT Theratechnologies Presents New In Vivo Pre-Clinical Data at AACR GlobeNewswire Inc

09:19AM EDT The Week Ahead In Biotech (April 11-17): Avenue Therapeutics FDA Decision and Conference Presentations In The Spotlight Benzinga

Mar 29, 2021

01:00PM EDT Theratechnologies Announces Two Strategic Hires to Support its GlobeNewswire Inc

Mar 24, 2021

08:02AM EDT Theratechnologies Announces First Patient Dosed In Phase 1 Clinical Trial Of TH1902 For Sortilin Positive Solid Tumors RTTNews

07:30AM EDT Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, is pleased to announce that the first patient received a dose of TH1902, its lead peptide-drug conjugate (PDC) for the treatment of sortilin positive (SORT1+) solid tumors. GlobeNewswire Inc

Mar 23, 2021

08:18AM EDT The Daily Biotech Pulse: FDA Approvals For Merck, Pacira And Zealand, Roche-Regeneron Ace Late-Stage COVID-19 Study, AlloVir Appoints Gilead Virology Chief As CEO Benzinga

01:31AM EDT AZN's COVID-19 Jab Shows 79% Efficacy, ZEAL Wins FDA RTTNews

Mar 20, 2021

11:37AM EDT Theratechnologies Says Data Demonstrating Positive Effect Of Tesamorelin On Immune Response Linked To Liver Inflammation RTTNews

11:00AM EDT Theratechnologies Announces New Data Demonstrating GlobeNewswire Inc

Mar 10, 2021

04:36PM EST Theratechnologies Reports 2 E-Posters To Be Presented At American Association For Cancer Research Apr. 10 Benzinga

04:30PM EST Theratechnologies Announces Two E-Posters on TH1902 To Be GlobeNewswire Inc

Mar 3, 2021

07:46AM EST The Daily Biotech Pulse: KemPharm ADHD Drug Gets The Nod, MediciNova Shelves Vaccine Study Benzinga

Mar 2, 2021

08:01AM EST The Daily Biotech Pulse: Roxadustat Delay For FibroGen, AstraZeneca, Decision Day For KemPharm, NanoViricides Jumps On COVID-19 Drug Data Benzinga

Feb 25, 2021

08:15AM EST Theratechnologies Q4 EPS $(0.07), Sales $19.12M Benzinga

07:30AM EST Theratechnologies Inc. (Theratechnologies, or Company) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced its financial results for the fourth quarter and its fiscal year ended November 30, 2020 (Fiscal 2020). GlobeNewswire Inc

04:03AM EST Earnings Scheduled For February 25, 2021 Benzinga

Feb 11, 2021

10:22AM EST Theratechnologies Inc. (TSX: TH) (NASDAQ: THTX) (Theratechnologies), a biopharmaceutical company focused on the development and commercialization of innovative therapies announced, today that it will issue its financial results for the fourth quarter and fiscal year ended November 30, 2020 on Thursday, February 25, 2021. GlobeNewswire Inc

Feb 4, 2021

08:24AM EST Theratechnologies' Peptide Conjugate Candidate For Solid Tumor Nabs Priority Review Tag In US, Shares Rally Benzinga

07:30AM EST Theratechnologies Lead Peptide Drug Conjugate GlobeNewswire Inc

Jan 25, 2021

09:07AM EST Piramal Pharma Solutions Reports Will Provide Theratechnologies With GMP Manufacturing Of Sterile Fill/Finish Drug Product To Support Developmental Product, No Terms Disclosed Benzinga

Jan 19, 2021

09:42AM EST Theratechnologies Announces Closing of US$46 Million Bought-Deal GlobeNewswire Inc

Jan 14, 2021

09:49AM EST Theratechnologies to Present at the B. Riley Securities Virtual GlobeNewswire Inc

Jan 12, 2021

08:16AM EST The Daily Biotech Pulse: GSK, Vir To Start COVID-19 Antibody Study, Novartis In-Licenses BeiGene's Cancer Drug, Earnings Preannouncements Continue Benzinga

Jan 11, 2021

08:20PM EST Theratechnologies Announces US$40 Million Bought-deal Public GlobeNewswire Inc

Jan 7, 2021

07:14AM EST Theratechnologies Sees Q4 Sales $18.9M-$19.2M Benzinga

07:12AM EST Theratechnologies Expects Q4 Consolidated Net Revenues To Be $18.9 Mln-$19.2 Mln RTTNews

07:00AM EST Theratechnologies Announces Preliminary Fourth Quarter and Full GlobeNewswire Inc

Dec 8, 2020

07:00AM EST In addition to ovarian and triple-negative breast cancers, TH1902 shows pre-clinical in vivo efficacy in colorectal, pancreatic, melanoma and endometrial cancers GlobeNewswire Inc

Nov 23, 2020

04:01PM EST Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced that some of its management team members will be participating in the upcoming Piper Sandler 32nd Annual Virtual Healthcare Conference on December 1 and 2, 2020. GlobeNewswire Inc

Nov 16, 2020

10:32AM EST Theratechnologies Highlights Data From Oral Presentation At American Association for the Study of Liver Diseases Showing How Tesamorelin Can Reduce Fibrosis, NASH Benzinga

10:31AM EST Theratechnologies Announces Data From Oral Presentation at AASLD GlobeNewswire Inc

Nov 6, 2020

01:38PM EST Theratechnologies Announces Data On Mechanism Of Effect Of Tesamorelin In NAFLD Will Be Presented At Liver Meeting 2020 Benzinga

01:36PM EST Theratechnologies Announces that Data on the Mechanism of Effect GlobeNewswire Inc

Nov 3, 2020

04:02PM EST Theratechnologies Announced The Departure Of Its Chief Commerical Officer Benzinga

04:01PM EST Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced that Jovan Antunovic, Senior Vice President and Chief Commercial Officer, is leaving the Company to assume a new position. His resignation will be effective November 13, 2020. GlobeNewswire Inc

Oct 16, 2020

07:38AM EDT Theratechnologies Appoints Andrew Molson And Alain Trudeau As New Independent Members RTTNews

07:30AM EDT Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced the appointment of Mr. Andrew Molson and Mr. Alain Trudeau as new independent members to its Board of Directors. GlobeNewswire Inc

Oct 15, 2020

07:09AM EDT Theratechnologies Q3 EPS $(0.09), Sales $14.05M Benzinga

07:00AM EDT Theratechnologies Inc. (Theratechnologies, or Company) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced its financial results for the third quarter of fiscal year 2020 ended August 31, 2020. GlobeNewswire Inc

04:08AM EDT Earnings Scheduled For October 15, 2020 Benzinga

Oct 14, 2020

10:22AM EDT Theratechnologies shares are trading higher after the company confirmed the USPTO issued its patent covering the use of Tesamorelin in the treatment of individuals suffering from NAFLD/NASH. Benzinga

Oct 13, 2020

04:38PM EDT Theratechnologies Confirms Issuance of U.S. Patent Covering the Use of Tesamorelin in the Treatment of Individuals Suffering From NAFLD/NASH Benzinga

04:37PM EDT Theratechnologies Confirms Issuance of U.S. Patent Covering the GlobeNewswire Inc

Oct 5, 2020

04:01PM EDT Theratechnologies Inc. (TSX: TH) (NASDAQ: THTX) (Theratechnologies) announced today that it will issue its financial results for the third quarter ended August 31, 2020 on Thursday, October 15, 2020. GlobeNewswire Inc

Sep 30, 2020

04:01PM EDT Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced that Dr. Christian Marsolais, Senior Vice President and Chief Medical Officer, will present at the H.C. Wainwright 4th Annual NASH Investor Conference on Monday, October 5, 2020 at 4:30 p.m. ET. GlobeNewswire Inc

Sep 21, 2020

07:31AM EDT Theratechnologies Sees Prelim. Q3 Sales $13.8M-$14.2M Benzinga

07:30AM EDT Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced select preliminary financial results for the third quarter ended August 31, 2020. GlobeNewswire Inc

Sep 10, 2020

07:36AM EDT Theratechnologies To Pursue Phase 3 Development Of Tesamorelin Benzinga

02:00AM EDT Theratechnologies Announces Launch of Trogarzo in Germany GlobeNewswire Inc

Jul 30, 2020

07:30AM EDT Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, today announced that Philippe Dubuc, the Senior Vice President and Chief Financial Officer of Theratechnologies, will present at the Canaccord Genuity Growth Conference on Wednesday, August 12, 2020 at 9:30 a.m. ET. GlobeNewswire Inc

Jul 23, 2020

04:33PM EDT Theratechnologies: Sub-analysis Of MGH Study Helps Better Show How Tesamorelin Reduces Liver Fat RTTNews

04:02PM EDT Theratechnologies Reports That Tesamorelin Improves Liver Health Benzinga

04:01PM EDT Sub-analysis of MGH study helps better demonstrate how tesamorelin reduces liver fat GlobeNewswire Inc

Jul 16, 2020

12:24PM EDT Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, today held its annual meeting of shareholders. GlobeNewswire Inc

Jul 15, 2020

07:40AM EDT Theratechnologies S2 Sales $17.12M, Up 10% YoY Benzinga

07:30AM EDT -Total product revenues of $17.2M, a 10% increase compared to Q2 2019 and 9% increase compared to Q1 2020- GlobeNewswire Inc

.dark-mode .jh4Jkk{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .jh4Jkk{ color: #333333; background-color: white; border: 2px solid #333333; }THTXTheratechnologies Inc. Commonstock NASDAQ

THTX
Theratechnologies Inc. Common
stock NASDAQ